documents: FDA-2005-D-0208-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2005-D-0208-0003 FDA FDA-2005-D-0208 Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency; Availability Notice NAD-Notice of Availability of Data 2008-07-17T04:00:00Z 2008 7 2008-07-17T04:00:00Z   2008-07-17T12:54:19Z E8-16395 0 0 090000648067fb8d

Links from other tables